CA VIII Activators
Carbonic Anhydrase VIII (CA VIII) Activators encompass a range of chemical compounds that indirectly enhance the functional activity of CA VIII through various neurologically relevant signaling pathways, primarily involving modulation of intracellular second messengers like cAMP. Forskolin, Dibutyryl-cAMP, Vinpocetine, and Rolipram, by increasing intracellular cAMP levels, activate PKA, which may influence various substrates and pathways, thereby potentially enhancing the functional activity of CA VIII. This enhancement likely takes place in the context of neuronal signaling and synaptic plasticity, which are crucial for cognitive functions and neuroprotection, areas where CA VIII is thought to play a significant role. Additionally, compounds like Sildenafil and Icariin, through their PDE inhibitory actions, contribute to a similar elevation of cAMP and cGMP, further potentiating the indirect activation of CA VIII by enhancing signaling pathways that lead to improved synaptic transmission and neuroprotection.
Furthermore, compounds such as Resveratrol, Curcumin, and Epigallocatechin gallate provide a broader spectrum of indirect activation through their multiple cellular effects, including modulation of various kinases and signaling molecules. These effects are thought to create a neuroprotective environment conducive to CA VIII activity. Caffeine, Huperzine A, and Ginkgolide B further extend the range of indirect CA VIII activators by influencing other aspects of neuronal function such as adenosine receptor antagonism, acetylcholinesterase inhibition, and circulation improvement, respectively. Collectively, these activators work in concert, primarily by modulating signaling pathways and cellular processes that are conducive to the functional activity of CA VIII, particularly in the realms of synaptic function, neuroprotection, and neuronal signaling. Thus, while not directly interacting with CA VIII, these compounds contribute to a cellular milieu that indirectly supports or enhances its activity, vital for maintaining cognitive and neuronal health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly enhances CA VIII activity by elevating cAMP levels, which could activate PKA. PKA can phosphorylate various substrates, potentially altering intracellular environments in ways that favor CA VIII activity, particularly in neuronal signaling and modulation of synaptic transmission where CA VIII is implicated. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, indirectly activates CA VIII by elevating intracellular cAMP levels, similar to Forskolin. This activation of PKA could lead to phosphorylation events that modulate neuronal activity and plasticity, functions associated with CA VIII, especially in the cerebellum. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine, a phosphodiesterase (PDE) inhibitor, indirectly enhances CA VIII function by inhibiting PDE, leading to an increase in cAMP levels. This elevation could activate PKA and subsequently influence pathways that regulate CA VIII activity, particularly in neuroprotective roles and modulation of synaptic plasticity. | ||||||
Icariin | 489-32-7 | sc-279198 sc-279198A sc-279198B | 1 g 5 g 10 g | $145.00 $421.00 $830.00 | ||
Icariin, a flavonoid compound known to act as a PDE inhibitor, might enhance CA VIII activity indirectly by increasing cAMP levels, subsequently activating PKA and affecting neuronal signaling pathways associated with CA VIII's functional roles in the brain. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, another selective PDE4 inhibitor, enhances CA VIII activity by increasing cAMP levels, leading to PKA activation. PKA activation might then influence neuronal pathways and synaptic functions associated with CA VIII, especially in cerebellar neurons. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, through its various cellular effects, could indirectly enhance CA VIII activity by modulating intracellular signaling pathways involved in neuroprotection and synaptic plasticity, processes in which CA VIII is implicated. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG), found in green tea, might indirectly activate CA VIII by modulating signaling pathways through its antioxidant and kinase modulating activities, especially those related to neuroprotection and cognitive functions where CA VIII is implicated. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, primarily acting as a phosphodiesterase inhibitor and an adenosine receptor antagonist, could indirectly enhance CA VIII activity by influencing neuronal signaling pathways, synaptic transmission, and plasticity, all domains where CA VIII is known to play a role. | ||||||
(−)-Huperzine A | 102518-79-6 | sc-200183 sc-200183A | 1 mg 5 mg | $143.00 $362.00 | 1 | |
Huperzine A, known for its role as an acetylcholinesterase inhibitor, may indirectly enhance CA VIII activity by increasing acetylcholine levels and thereby affecting synaptic plasticity and signaling pathways where CA VIII is involved, particularly in cognitive functions. | ||||||
Ginkgolide A | 15291-75-5 | sc-205705 sc-205705A sc-205705B sc-205705D sc-205705C | 10 mg 25 mg 250 mg 1 g 500 g | $68.00 $162.00 $414.00 $1130.00 $693.00 | 2 | |
Ginkgolide B, a component of Ginkgo biloba, might enhance CA VIII activity indirectly through its neuroprotective and circulatory benefits. By modulating neuronal signaling and vascular dynamics, it could create conditions favorable for CA VIII's functional roles in the brain. | ||||||